Table 3. Reported results with... | American Society of Hematology

Table 3.

Reported results with monoclonal antibody therapy in chronic lymphocytic leukemia (CLL).

Regimen	Previously Untreated	Prior Rx	Dose (4-week schedule)	%CR + PR	Ref.
Abbreviations: CR, complete response; PR, partial response
Rituximab	43	—	375 mg/m² qw × 4	9 + 49	46
	6	27	375 mg/m² tiw × 4	3 + 42	40
	—	50	500–2250 mg/m² qw × 4	0 + 36	41
Campath	0	93	30 mg tiw × 12 wks IV	2 + 31	42
	38	—	30 mg tiw × 18 wks SC	19 + 68	43

Regimen	Previously Untreated	Prior Rx	Dose (4-week schedule)	%CR + PR	Ref.
Abbreviations: CR, complete response; PR, partial response
Rituximab	43	—	375 mg/m² qw × 4	9 + 49	46
	6	27	375 mg/m² tiw × 4	3 + 42	40
	—	50	500–2250 mg/m² qw × 4	0 + 36	41
Campath	0	93	30 mg tiw × 12 wks IV	2 + 31	42
	38	—	30 mg tiw × 18 wks SC	19 + 68	43